Additionally, elevated VEGF may contribute to more aggressive HCC characteristics, such as infiltrative or metastatic transformations, and the formation of collateral tumor blood supplies, which can lead to resistance against TACE treatment [34]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.